Liu et al. also reported more pronounced decrease in the rate of Akt and Erk phosphorylation after incubation with combinations of foretinib with erlotinib or lapatinib in the presence of HGF for a panel of human cancer cell lines [22]. The gene discussed is AKT1; the disease is cancer.